ornithine and Arteriosclerosis, Coronary

ornithine has been researched along with Arteriosclerosis, Coronary in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aberer, F; Aziz, F; Brachtl, G; Brodmann, M; Dimsity, G; Hafner, F; Hödl, R; Meinitzer, A; Riedl, R; Sourij, H; Stojakovic, T; Strunk, D; Tripolt, NJ; Url, J	1
Brennan, DM; Cho, L; Hazen, SL; Tang, WH; Wang, Z	2
Eder, M; Meinitzer, A; Pieber, TR; Sourij, H; Tripolt, NJ; Wascher, TC	1

Trials

2 trial(s) available for ornithine and Arteriosclerosis, Coronary

Article	Year
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial. Cardiovascular diabetology, 2018, 05-17, Volume: 17, Issue:1 Topics: Aged; Arginine; Austria; Biomarkers; Blood Glucose; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Linagliptin; Lipids; Male; Middle Aged; Ornithine; Postprandial Period; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation	2018
Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:10 Topics: Aged; Anticholesteremic Agents; Arginine; Biological Availability; Blood Pressure; Cholesterol, LDL; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Prospective Studies; Risk Factors; Time Factors	2012

Article

Year

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.

Cardiovascular diabetology, 2018, 05-17, Volume: 17, Issue:1

Topics: Aged; Arginine; Austria; Biomarkers; Blood Glucose; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Linagliptin; Lipids; Male; Middle Aged; Ornithine; Postprandial Period; Prospective Studies; Time Factors; Treatment Outcome; Vasodilation

2018

Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios.

Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:10

Topics: Aged; Anticholesteremic Agents; Arginine; Biological Availability; Blood Pressure; Cholesterol, LDL; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Prospective Studies; Risk Factors; Time Factors

2012

Other Studies

2 other study(ies) available for ornithine and Arteriosclerosis, Coronary

Article	Year
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. Journal of the American College of Cardiology, 2009, Jun-02, Volume: 53, Issue:22 Topics: Aged; Arginine; Biological Availability; C-Reactive Protein; Citrulline; Confidence Intervals; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Odds Ratio; Ornithine; Prognosis; Prospective Studies; Risk Assessment; Risk Factors	2009
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:9 Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors	2009

Article

Year

Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.

Journal of the American College of Cardiology, 2009, Jun-02, Volume: 53, Issue:22

Topics: Aged; Arginine; Biological Availability; C-Reactive Protein; Citrulline; Confidence Intervals; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Odds Ratio; Ornithine; Prognosis; Prospective Studies; Risk Assessment; Risk Factors

2009

Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.

Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:9

Topics: Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Citrulline; Coronary Artery Disease; Creatinine; Female; Humans; Lysine; Male; Metabolomics; Methylation; Middle Aged; Nitric Oxide Synthase; Odds Ratio; omega-N-Methylarginine; Ornithine; Prognosis; Prospective Studies; Protein Processing, Post-Translational; Risk Assessment; Risk Factors; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Time Factors

2009